EST
FLGT icon

EA Series Trust’s Fulgent Genetics FLGT Stock Holding History

EA Series Trust’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.13M Buy
+84,492
New +$2.95M 0.11% 252

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

EA Series Trust's FLGT Position: Q2 2023 in Review

EA Series Trust opened a new position in Fulgent Genetics (FLGT) in Q2 2023: 84,492 shares worth $3.13M. The stake represents 0.11% of the portfolio and ranks #252 among its holdings.

214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • EA Series Trust held 84,492 shares of Fulgent Genetics worth $3.13M as of Q2 2023.
  • Fulgent Genetics was a new EA Series Trust position in Q2 2023.
  • Fulgent Genetics made up 0.11% of EA Series Trust's portfolio in Q2 2023, its #252 holding.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.